Identification of a novel protein encoded by the BamHI a region of the Epstein-Barr virus

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2765-2771

  Fries, Katherine L ^a   Sculley, Tom B ^a,b   Webster Cyriaque, Jennifer ^a   Rajadurai, Pathmanathan ^c   Sadler, Robert H ^a   Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; RNA; VIRUS PROTEIN;

ARTICLE; BURKITT LYMPHOMA; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030897103     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2765-2771.1997     Document Type: Article

References (48)

1. Abbot, S. D., M. Rowe, K. Cadwallader, A. Ricksten, J. Gordon, F. Wang, L. Rymo, and A. B. Rickinson. 1990. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. J. Virol. 64:2126-2134.
2. Allday, M. J., D. H. Crawford, and J. A. Thomas. 1993. Epstein-Barr virus nuclear antigen 6 induces expression of the Epstein-Barr virus latent membrane protein and an activated phenotype in Raji cells. J. Gen. Virol. 74: 661-669.
3. 1-arrested cells. J. Virol. 68:3491-3498.
4. Brooks, L. A., A. L. Lear, L. S. Young, and A. B. Rickinson. 1993. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of latency. J. Virol. 67:3182-3190.
5. Busson, P., G. Ganem, P. Flores, F. Mugneret, B. Clauss, B. Caillou, K. Braham, H. Wakasugi, M. Lipinski, and T. Tursz. 1988. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int. J. Cancer 42:599-606.
6. Busson, P., R. McCoy, R. Sadler, K. Gilligan, T. Tursz, and N. Raab-Traub. 1992. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J. Virol. 66:3257-3262.
7. Chen, H. L., M. M. Lung, J. S. Sham, D. T. Choy, B. E. Griffin, and M. H. Ng. 1992. Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 191:193-201.
8. Chen, M. R., J. M. Middeldorp, and S. D. Hayward. 1993. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67:4875-4885.
9. Desgranges, C., H. Wolf, G. de The, K. Shanmugaratnam, R. Ellouz, N. Cammoun, G. Klein, and H. zur Hausen. 1975. Nasopharyngeal carcinoma. X. Presence of Epstein-Barr virus genomes in epithelial cells of tumors from high and medium risk areas. Int. J. Cancer 16:7-15.
10. de The, G. 1982. Epidemiology of Epstein-Barr virus and associated diseases, p. 25-87. In B. Roizman (ed.), The herpesviruses, Plenum Press, New York, N.Y.
11. Fahraeus, R., H. L. Fu, I. Ernberg, J. Finke, M. Rowe, G. Klein, K. Falk, E. Nilsson, M. Yadav, P. Busson, T. Tursz, and B. Kallin. 1988. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer 42:329-338.
12. Fahraeus, R., A. Jansson, A. Ricksten, A. Sjoblom, and L. Rymo. 1990. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. Natl. Acad. Sci. USA 87:7390-7394.
13. Geser, A., G. Lenoir, M. Anvret, G. W. Bornkamm, G. Klein, E. H. Williams, D. H. Wright, and G. de The. 1983. Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda. Eur. J. Cancer Clin. Oncol. 19:1394-1404.
14. Ghosh, D., and E. Kieff. 1990. cis-Acting regulatory elements near the Epstein-Barr virus latent infection membrane protein transcriptional start site. J. Virol. 64:1855-1858.
15. Gilligan, K., P. Rajadurai, L. Resnick, and N. Raab-Traub. 1990. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA 87:8790-8794.
16. Gilligan, K., H. Sato, P. Rajadurai, P. Busson, L. Young, A. Rickinson, T. Tursz, and N. Raab-Traub. 1990. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J. Virol. 64:4948-4956.
17. Gilligan, K. J., P. Rajadurai, J. C. Lin, P. Busson, M. Abdel-Hamid, U. Prasad, T. Tursz, and N. Raab-Traub. 1991. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J. Virol. 65:6252-6259.
18. Greenspan, J. S., D. Greenspan, E. T. Lenette, D. I. Abrams, M. A. Conany, V. Peterson, and U. K. Freese. 1985. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukopiakia, an AIDS associated lesion. N. Engl. J. Med. 313:1564-1571.
19. Gregory, C. D., M. Rowe, and A. B. Rickinson. 1990. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J. Gen. Virol. 71:1481-1495.
20. Hanto, D. W., G. F. Frizzera, K. J. Gajl-Peczalska, K. Sakamoto, D. T. Purtilo, H. H. Balfour, R. L. Simmons, and J. S. Najarian. 1982. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. N. Engl. J. Med. 306:913-918.
21. Hitt, M. M., M. Allday, T. Hara, L. Karran, M. D. Jones, P. Busson, T. Tursz, I. Ernberg, and B. Griffin. 1989. EBV gene expression in an NPC-related tumor. EMBO J. 8:2639-2651.
22. Karran, L., Y. Gao, P. Smith, and B. E. Griffin. 1992. Expression of a family of EB virus complementary strand transcripts in latently infected cells. Proc. Natl. Acad. Sci. USA 89:8058-8062.
23. Katz, B. Z., N. Raab-Traub, and G. Miller. 1989. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J. Infect. Dis. 160:589-594.
24. Kim, O. J., and J. L. Yates. 1993. Mutants of Epstein-Barr virus with a selectable marker disrupting the TP gene transform B cells and replicate normally in culture. J. Virol. 67:7634-7640.
25. King, W., A. L. Thomas-Powell, N. Raab-Traub, M. Hawke, and E. Kieff. 1980. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected growth-transformed cell line. J. Virol. 36:506-518.
26. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
27. Longnecker, R., C. Miller, X.-Q. Miao, B. Tomkinson, and E. Kieff. 1992. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP 2A) from LMP 2B is dispensable for lymphocyte infection and growth transformation in vitro. J. Virol. 66:6461-6464.
28. Longnecker, R., C. L. Miller, X.-Q. Miao, B. Tomkinson, and E. Kieff. 1993. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. J. Virol. 67:2006-2013.
29. Longnecker, R., C. L. Miller, B. Tomkinson, X.-Q. Miao, and E. Kieff. 1993. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J. Virol. 67:5068-5074.
30. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70:190-194.
31. Pope, J., M. Horne, and W. Scott. 1968. Transformation of fetal human leukocytes in vitro by filtrates of a human leukemic cell line containing herpes-like virus. Int. J. Cancer 3:857-866.
32. Raab-Traub, N., and K. Flynn. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 22:257-267.
33. Raab-Traub, N., K. Flynn, G. Pearson, A. Huang, P. Levine, A. Lanier, and J. Pagano. 1987. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int. J. Cancer 39:25-29.
34. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
35. Robertson, E. S., B. Tomkinson, and E. Kieff. 1994. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. J. Virol. 68:1449-1458.
36. Rowe, M., H. S. Evans, L. S. Young, K. Hennessy, E. Kieff, and A. B. Rickinson. 1987. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus revealed heterogeneity of the protein and inducible expression in virus-transformed cells. J. Gen. Virol. 68:1575-1586.
37. Rowe, M., D. T. Rowe, C. D. Gregory, L. S. Young, P. J. Farrell, H. Rupani, and A. B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:2743-2751.
38. Sadler, R. H., and N. Raab-Traub. 1995. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J. Virol. 69:1132-1141.
39. Sculley, T. B., T. Kreofsky, G. R. Pearson, and T. C. Spelsberg. 1983. Partial purification of the Epstein-Barr virus nuclear antigen(s). J. Biol. Chem. 258:3974-3982.
40. Smith, P. R., Y. Gao, L. Karrin, M. D. Jones, D. Snudden, and B. E. Griffin. 1993. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J. Virol. 67:3217-3225.
41. Takada, K. 1984. Cross-linking of cell surface immunoglobulin induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33:27-32.
42. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of the latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
43. Tomkinson, B., and E. Kieff. 1992. Second-site homologous recombination in Epstein-Barr virus: insertion of type I EBNA 3 genes in place of type 2 has no effect on in vitro infection. J. Virol. 66:780-789.
44. Wang, F., S.-F. Tsang, M. G. Kurilla, J. I. Cohen, and E. Kieff. 1990. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 64:3407-3416.
45. Young, L. S., C. Alfieri, K. Hennessy, H. Evans, C. O'Hara, K. C. Anderson, J. Ritz, R. S. Shapiro, A. Rickinson, E. Kieff, and J. I. Cohen. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
46. Zimber, S. U., E. Kremmer, F. Grasser, G. Marschall, G. Laux, and G. W. Bornkamm. 1993. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12:167-175.
47. Zimber-Strobl, U., K. O. Suentzenich, G. Laux, D. Eick, M. Cordier, A. Calender, M. Billaud, G. M. Lenoir, and G. W. Bornkamm. 1991. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol. 65:415-123.
48. zur Hausen, H., H. Schulte-Holthausen, G. Klein, W. Henley, G. Henley, P. Clifford, and L. Santesson. 1970. EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 228:1056-1058.